Jonesboro Belviq Lawyers
File Your Belviq Cancer Lawsuit with Wells & Wells
In February of 2020, the U.S. Food and Drug Administration (FDA) asked Eisai Inc. to recall 2 of its products – Belviq and Belviq XR – from U.S. markets. In a double-blind study, this prescription weight-loss medication increased patients’ risk of pancreatic, colorectal, and lung cancer.
Unfortunately, many people who took Belviq to curb their appetite and help them lose weight put themselves at serious risk instead. While obesity and weight-related health problems can be dangerous, cancer is undoubtedly worse.
If you or a loved one suffered a cancer diagnosis after taking Belviq, Belviq XR, or any other brand of the weight-loss drug, lorcaserin, you may be entitled to compensation.
Wells & Wells can help you hold Eisa Inc. and other manufacturers accountable and recover the money you need for treatment.
Call us at (870) 782-4084 to get started with a free consultation – you pay nothing unless we win.
What Is Belviq?
Belviq and Belviq XR are brand names of a weight-loss medication called lorcaserin. While they were on the market, doctors prescribed these drugs to treat obesity and weight-related health issues. Similar to serotonin reuptake inhibitors (SSRIs) like antidepressants, Belviq activates serotonin receptors in the brain. Serotonin can trigger feelings of well-being like happiness, satisfaction, and feeling full, so Belviq focuses on the serotonin receptors that affect appetite.
By using Belviq to control their appetite, people with obesity were able to lose weight. People who took Belviq tablets typically lost 5% of their body weight during their first 12 weeks of combining the drug with a low-calorie diet.
Sadly, these people unknowingly put their health in danger while trying to achieve a healthier lifestyle.
Does Belviq Cause Cancer?
Although no official sources have confirmed Belviq causes cancer, the FDA found that the drug does, in fact, increase the risk of cancer.
The FDA approved lorcaserin in 2012 but required the drug manufacturer to further investigate the risk of cardiovascular problems. During the study, the manufacturer did not find evidence of increased cardiovascular problems but did uncover that people who took lorcaserin were at a higher risk of cancer, particularly cancers of the pancreas, colon, and lungs.
Upon reviewing this information, the FDA asked Eisai Inc. to remove Belviq and Belviq XR from the market. The FDA believes the risks of lorcaserin outweigh its benefits.
At Wells & Wells, we understand how shocking it may be to find out a prescribed, FDA-approved drug may have increased your risk of cancer.
Eisai Inc. is responsible for the products it put on the market, and our Jonesboro Belviq attorneysare here to help you hold them accountable for your cancer diagnosis and treatment costs.
What Damages Can I Recover?
On average, cancer treatment costs about $150,000. A successful settlement or verdict in your Belviq cancer lawsuit can help you cover your treatment expenses and missed wages while you recover, and account for any pain and suffering you experience. Broadly speaking, you can recover any damages associated with your cancer diagnosis, so the amount of compensation you receive will depend on the details of your case.
Any person over the age of 18 who receives a cancer diagnosis after taking Belviq, Belviq XR, or another brand of lorcaserin is eligible to file a lawsuit.
With over 50 years of combined legal experience, Wells & Wells can help you put together your case and recover maximum compensation. Our family firm is ready to do what it takes to secure your family’s future, and we have the awards and accolades to prove it.
To learn more about our firm and get the personalized and attentive representation you deserve, call us at (870) 782-4084 today or send us a message online– we’ll be in touch within 24 hours to help you schedule your free consultation.